TipRanks
Go Ultimate55% OFF

Andrew Cittadine Insider Profile

116 Followers

Andrew Cittadine, COO at Monopar Therapeutics Inc, holds 55.61K shares in Monopar Therapeutics Inc (Ticker: MNPR).

Andrew Cittadine's Trading History

MNPR
Monopar Therapeutics Inc
Jul 02, 2026COOUninformative Buy272.68K$3.91M
MNPR
Insider Shares: 55.61K (0.83%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jul 02, 2026Uninformative Buy$272.68K2,945$92.59―
Apr 02, 2026Uninformative Buy$106.46K1,943$54.79―
Oct 02, 2025Uninformative Buy$198.54K2,431$81.67―
Jul 02, 2025Uninformative Buy$138.58K3,873$35.78―
Apr 02, 2025Uninformative Buy$38.12K1,047$36.41―

You May Also Like

Andrew Cittadine insider profile FAQ

What is the percentage of profitable transactions made by Andrew Cittadine?
The percentage of profitable transactions made by Andrew Cittadine is 80%.
What is the average return per transaction made by Andrew Cittadine?
The average return per transaction made by Andrew Cittadine is 601.00%.
What stocks does Andrew Cittadine hold?
Andrew Cittadine holds: MNPR stocks.
What was Andrew Cittadine’s latest transaction?
Andrew Cittadine’s latest transaction was an Uninformative Buy of $272.68K.
What was Andrew Cittadine's most profitable transaction?
Andrew Cittadine’s most profitable transaction was an Informative Buy of MNPR stock on May 31, 2024. The return on the trade was 800.00%.
What is Andrew Cittadine's role in Monopar Therapeutics Inc?
Andrew Cittadine's role in Monopar Therapeutics Inc is COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.